IHL results are for inflammatory bowel disease, not IBS.
Also combining CBD with other compounds and have multiple trials running with patents pending and chasing FDA approval.
can't really draw a direct comparison between the two companies market caps.
I hold both but for different reasons and i think EMDs approach will make them the quickest to the OTC market in australia for CBD products
IHL results are for inflammatory bowel disease, not IBS. Also...
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.004(8.00%) |
Mkt cap ! $16.86M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.6¢ | $34.53K | 720.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 199999 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.7¢ |
Change
-0.004 ( 6.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.9¢ | 4.9¢ | 4.7¢ | 122194 | ||
| Last updated 15.01pm 08/05/2024 ? | |||||
| EMD (ASX) Chart |